Fidaxomicin is an oral antibiotic used primarily to treat Clostridium difficile infection (CDI), a serious bacterial infection affecting the gastrointestinal tract. It is marketed under the brand name Dificid. As a macrolide antibiotic, fidaxomicin works by inhibiting bacterial RNA polymerase, leading to the death of the bacteria.
